These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 33075684)
1. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review. Belkouz A; Nooijen LE; Riady H; Franken LC; van Oijen MGH; Punt CJA; Erdmann JI; Klümpen HJ Cancer Treat Rev; 2020 Dec; 91():102110. PubMed ID: 33075684 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma: A Retrospective Cohort Study. Nooijen LE; Franken LC; Belkouz A; Oulad Abdennabi I; Besselink MG; Busch OR; Swijnenburg RJ; Klümpen HJ; Erdmann JI Am J Clin Oncol; 2021 Oct; 44(10):526-532. PubMed ID: 34469345 [TBL] [Abstract][Full Text] [Related]
3. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849 [TBL] [Abstract][Full Text] [Related]
4. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Polistina FA; Guglielmi R; Baiocchi C; Francescon P; Scalchi P; Febbraro A; Costantin G; Ambrosino G Radiother Oncol; 2011 May; 99(2):120-3. PubMed ID: 21621289 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of neoadjuvant chemotherapy based on our resectability criteria for locally advanced perihilar cholangiocarcinoma. Gyoten K; Kuriyama N; Maeda K; Ito T; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kishiwada M; Mizuno S Langenbecks Arch Surg; 2023 Jul; 408(1):261. PubMed ID: 37392289 [TBL] [Abstract][Full Text] [Related]
6. Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study. Im JH; Yu JI; Kim TH; Kim TG; Kim JW; Seong J Cancer Res Treat; 2024 Jul; 56(3):838-846. PubMed ID: 38186240 [TBL] [Abstract][Full Text] [Related]
7. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience. Ghiringhelli F; Lorgis V; Vincent J; Ladoire S; Guiu B Chemotherapy; 2013; 59(5):354-60. PubMed ID: 24821200 [TBL] [Abstract][Full Text] [Related]
9. Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma. Madzikatire TB; Heng S; Gu H; Shan Y; Lin E; Banda J; Debora A; Madziva BA; Bowa MJ; Mudhuri MG; Bwalya C Front Immunol; 2024; 15():1390887. PubMed ID: 38846939 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis. Takahashi D; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Maeda O; Ando M; Ebata T J Hepatobiliary Pancreat Sci; 2021 Sep; 28(9):716-726. PubMed ID: 34087061 [TBL] [Abstract][Full Text] [Related]
11. Comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma". Mungmungpuntipantip R; Wiwanitkit V J Hepatobiliary Pancreat Sci; 2022 Apr; 29(4):e28. PubMed ID: 34748290 [No Abstract] [Full Text] [Related]
12. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839 [TBL] [Abstract][Full Text] [Related]
13. Reply to comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma". Takahashi D; Mizuno T; Ebata T J Hepatobiliary Pancreat Sci; 2022 Apr; 29(4):e29. PubMed ID: 34748277 [No Abstract] [Full Text] [Related]
14. A New Strategy of Liver Transplantation for Locally Advanced Unresectable Perihilar Cholangiocarcinoma Using Living Grafts With Simultaneous Resection of Recipients' Hepatic Artery and Portal Vein Without Neoadjuvant Radiation: A Case Report. Miyagi S; Fujio A; Nakagawa K; Tokodai K; Kashiwadate T; Miyazawa K; Sasaki K; Matsumura M; Nishimaki H; Hibi T; Kamei T; Unno M Transplant Proc; 2022; 54(6):1643-1647. PubMed ID: 35810018 [TBL] [Abstract][Full Text] [Related]
15. [A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma]. Aoki Y; Suzuki T; Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M Gan To Kagaku Ryoho; 2014 Nov; 41(12):1509-11. PubMed ID: 25731235 [TBL] [Abstract][Full Text] [Related]
16. Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Zhang M; Qi W; Qiu X; Yu C; Qiu W; Wang S; Qiu Z Radiol Oncol; 2023 Dec; 57(4):419-429. PubMed ID: 38038416 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392 [TBL] [Abstract][Full Text] [Related]
18. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750 [TBL] [Abstract][Full Text] [Related]
19. Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study. Pietge H; Sánchez-Velázquez P; Akhoundova D; Siebenhüner A; Winder T; Bachmann H; Nguyen-Kim TDL; Breitenstein S; Knuth A; Petrowsky H; Pestalozzi B; Clavien PA; Samaras P Oncology; 2021; 99(5):300-309. PubMed ID: 33657549 [TBL] [Abstract][Full Text] [Related]